𝔖 Bobbio Scriptorium
✦   LIBER   ✦

300: Once Daily Busulfan Cyclophosphamide is Well Tolerated and Effective Prior to Allogeneic Hematopoietic Stem Cell Transplantation

✍ Scribed by J. LeMaistre; C. Bachier; B. Smith; C.F. LeMaistre; P.J. Shaughnessy

Book ID
116280127
Publisher
Elsevier Science
Year
2008
Tongue
English
Weight
49 KB
Volume
14
Category
Article
ISSN
1083-8791

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

229: Twice-Daily Intravenous (IV) Busulf
229: Twice-Daily Intravenous (IV) Busulfan (Bu) x 4 Days in Children Undergoing a Reduced-Intensity Conditioning (RIC) Regimen with Allogeneic Hematopoietic Stem Cell Transplantation (AlloHSCT) is Safe and Well-Tolerated but Results in Significantly Increased Bu Clearance (CL) and Decreased Area Under the Curve (AUC) and Half-Life (t1/2) When Compared to IV Bu Twice-Daily Dosing Pharmacokinetics (PK) in Adults
✍ I. Waxman; M. Bhatia; M. Milone; L.M. Shaw; L. Baldinger; O. Militano; J. Garvin πŸ“‚ Article πŸ“… 2008 πŸ› Elsevier Science 🌐 English βš– 60 KB